MedTrace Logo

Efficacy Study in Patients With Acne Vulgaris.

NCT02935036 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 294

Last updated 2018-10-18

Study results available
· View outcomes & findings →

Summary

Safety and efficacy study in patients with acne vulgaris

Conditions

  • Acne Vulgaris

Interventions

DRUG

ADPS topical product

topical product

DRUG

Placebo Control

topical product

Sponsors & Collaborators

  • Sun Pharmaceutical Industries, Inc.

    lead INDUSTRY

Principal Investigators

  • Catawba Research · http://catawbaresearch.com/contact/

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-03
Primary Completion
2017-01-24
Completion
2017-03-21

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02935036 on ClinicalTrials.gov